Podcast: Benefits of a Hybrid Operating Room
Tom Edwards, director of heart and vascular services at Northeast Georgia Health System, discusses why they added imaging equipment to the operating room.
[[{"type":"media","view_mode":"media_crop","fid":"8129","attributes":{"alt":"Tom Edwards","class":"media-image media-image-left","id":"media_crop_3164188437893","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"211","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 5px; float: left;","title":"","typeof":"foaf:Image"}}]]Tom Edwards, director of heart and vascular services at Northeast Georgia Health System in Gainesville, was the self-described “poster child” against developing a hybrid operating room. He heard from critics that the heavy-duty imaging equipment added to an operating room would just get pushed aside.
But the hospital management team saw a need and a demand for the inclusion of fluoroscopy equipment used in a catheterization lab in their new operating room. So they moved forward with creating the endovascular OR, which Williams said has exceeded expectations.
In this podcast, Edwards describes the process and the reaction to their hybrid OR.
[[{"type":"media","view_mode":"media_crop","fid":"8130","attributes":{"alt":"Northeast Georgia Health System in Gainesville, FL","class":"media-image","id":"media_crop_4625862987498","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"212","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":"","typeof":"foaf:Image"}}]]
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
